Immediate Impact

2 by Nobel laureates 10 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

Late-stage Functionalization for Improving Drug-like Molecular Properties
2023 Standout
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
2023 Standout
1 intermediate paper

Works of David Anderson being referenced

Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study
2022
The Intelence aNd pRezista Once A Day Study (INROADS): a multicentre, single‐arm, open‐label study of etravirine and darunavir/ritonavir as dual therapy in HIV‐1‐infected early treatment‐experienced subjects
2015

Author Peers

Author Last Decade Papers Cites
David Anderson 464 412 280 45 970
Dénes Bánhegyi 524 589 202 55 1.1k
Maximilian Muenchhoff 228 567 226 47 1.0k
Anne Krivine 395 599 466 40 1.1k
Lewis McCurdy 317 441 449 38 988
Dan Ouchi 336 419 140 49 748
Christine Armbruster 316 212 244 50 895
Edward D. Blair 508 472 363 27 1.1k
Meagan P. O’Brien 384 360 342 35 1.0k
David M. Tehrani 577 216 228 38 1.1k
D. Torre 134 187 316 47 798

All Works

Loading papers...

Rankless by CCL
2026